Science & Technology
Sbir Base Year - Topic 130 Adjuvant Discovery and Down-Selection for Vaccines Against Infectious and Immune-Mediated Diseases
Department of Health and Human Services — National Institutes of Health
Opportunity #: 75N93025C00007
Award Ceiling
$3.0M
Award Floor
$3.0M
Close Date
N/A
Total Funding
$3.0M
Expected Awards
1
Cost Sharing Required
No
Grants.gov ID
sbir-75N93025C00007
Description
SBIR Phase Phase II award: "SBIR BASE YEAR - TOPIC 130 ADJUVANT DISCOVERY AND DOWN-SELECTION FOR VACCINES AGAINST INFECTIOUS AND IMMUNE-MEDIATED DISEASES" awarded to Adjuvax LLC in Hoover, Alabama. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $3,000,000. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.